Aayush is a Partner in the Corporate and M&A, Private Equity & Venture Capital practice of the Firm. He has significant experience in having advised private equity firms, strategic investors, multinational corporations, as well as founders on domestic and cross-border transactions across a broad range of sectors including infrastructure, healthcare, pharmaceutical, hospitals, manufacturing and e-commerce. Aayush also has experience in strategizing, managing and settlement of disputes arising from M&A transactions, and corporate advisory on business-as-usual matters.
Aayush holds a B.B.A. LL.B degree from Symbiosis Law School, Pune.
API Holdings (PharmEasy) and its founders on the various funding rounds of the company of over USD 500 million.
Think Investments on its investments in various entities in the technology sector.
DP World on its acquisition of a controlling stake in Kribhco Infrastructure Limited (for a confidential deal value).
Edelweiss Alternative Asset Advisors on its acquisition of 4 Essel Infra’s power transmission assets, for an approximate consideration of INR 6000 crores.
Indigrid on its proposed acquisition of power transmission assets of the Sterlite group.
Merck on the sale of its consumer health business to Procter & Gamble, for an approximate consideration of USD 4.2 billion.
CVC Capital on its acquisition of a majority stake in HealthCare Global, for an approximate consideration of INR 1100 crores.
Diageo Plc on its acquisition of a majority stake in United Spirits Limited, for an approximate consideration of USD 2.2 billion.
Cemex on its proposed acquisition of an Indian listed company (approx. USD 1.5 billion).
CDC on its equity and debt investments in Veritas Finance, for an approximate consideration of USD 10 million.
iCapital Group on its investment in an InterGlobe group company engaged in technology services, for an approximate consideration of USD 200 million.
Pidilite Industries on its joint venture with Italian wood finish manufacturer ICA.
LeapFrog Investment on its investment in Disha Microfin, for an approximate overall transaction consideration of INR 500 crores.
GE Capital on its divestment of shares in various portfolio companies in India.
Access India Fund on its investment in procurement intelligence firm Beroe, for an approximate consideration of USD 10 million.
InvAscent on its investment in eye care chain Sharp Sigh, for an approximate consideration of INR 70 crores.
InvAscent on its investment in API manufacturer Symbiotec, for an approximate overall transaction consideration of USD 100 million.
Everstone on its proposed acquisition of a controlling stake in a clothing brand.
Bar Council of Maharashtra & Goa
7A, 7th Floor, Tower C, Max House,
Okhla Industrial Area, Phase 3,
New Delhi – 110020
The rules of the Bar Council of India do not permit advocates to solicit work or advertise in any manner. This website has been created only for informational purposes and is not intended to constitute solicitation, invitation, advertisement or inducement of any sort whatsoever from us or any of our members to solicit any work in any manner. By clicking on 'Agree' below, you acknowledge and confirm the following:
a) there has been no solicitation, invitation, advertisement or inducement of any sort whatsoever from us or any of our members to solicit any work through this website;
b) you are desirous of obtaining further information about us on your own accord and for your use;
c) no information or material provided on this website is to be construed as a legal opinion and use of this website will not create any lawyer-client relationship;
d) while reasonable care has been taken in ensuring the accuracy of the contents of the website, Argus Partners shall not be responsible for the results of any actions taken on the basis of information provided in this website or for any error or omission in the website; and
e) in cases where the user has any legal issues, the user must seek independent legal advice.
